These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 7224818

  • 1. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
    Nowak C, Arnold W, Henneberger G, Tanneberger S.
    Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical controlled trial in advanced breast cancer: CMFV (cyclophosphamide, methotrexate, fluorouracil, vincristine) verus CD (carminomycin, dibromodulcitol).
    Neoplasma; 1982; 29(6):741-7. PubMed ID: 6761595
    [Abstract] [Full Text] [Related]

  • 5. [Polyamines and their significance for control of cancer chemotherapy (author's transl)].
    Nissen E, Dettmer R, Fiedler D, Bodammer M.
    Arch Geschwulstforsch; 1980; 50(4):336-40. PubMed ID: 7458581
    [Abstract] [Full Text] [Related]

  • 6. [Effect of a mixture of carminomycin and cyanoacrylates on experimental tumor growth].
    Chissov VI, Rusakov IG, Akimova AIa, Shchitkov KG.
    Vopr Onkol; 1982; 28(6):41-5. PubMed ID: 7090296
    [No Abstract] [Full Text] [Related]

  • 7. Recent results with clinically used antineoplastic drugs and drug combinations in vivo.
    Arnold W, Tanneberger S, Nowak C, Naundorf H.
    Oncology; 1980; 37 Suppl 1():34-41. PubMed ID: 7454199
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I.
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 11. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H, Fritsch H, Drings P, Moskwa G, von Kaick G.
    Med Klin; 1974 Apr 26; 69(17):750-6. PubMed ID: 4837493
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G, Kratzer H, Denz H, Huber H.
    Wien Klin Wochenschr; 1981 Mar 20; 93(6):205-7. PubMed ID: 7281697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light.
    Cowled PA, Mackenzie L, Forbes IJ.
    Cancer Res; 1987 Feb 15; 47(4):971-4. PubMed ID: 2948637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.